VEGFA and choroidal neovascularization: Although anti-VEGF therapy has been a breakthrough in the treatment of wAMD, unfortunately, up to a quarter of anti-VEGF-treated wAMD patients might not benefit from intravitreal injections and choroidal neovascularization (CNV) activity does not respond to the treatment.